Notícias

The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines1,2....

The emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines1,2....

Coronavirus disease 2019 [COVID-19] is a global health threat caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV2] that requires...

Rapidly emerging SARS-CoV-2 variants jeopardize antibody-based countermeasures. Although cell culture experiments have demonstrated a loss of potency of several anti-spike...

ABIFINA comemora 35 anos com uma apresentação do embaixador
Rubens Barbosa e entrega do Prêmio Alcebíades de Mendonça Athayde...

Coronavirus disease 2019 (COVID-19) is the newly emerging viral disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The...

A ABIFINA chega aos 35 anos com a sólida reputação de ser uma entidade ética e
defensora do interesse...

Lançada em reunião do CNCP no dia 17 de junho

A ABIFINA foi convidada a integrar o Fórum da Geração Ecológica da Comissão de
Meio Ambiente (CMA) do Senado...

The efficacy and safety of tofacitinib, a Janus kinase inhibitor, in patients who are hospitalized with coronavirus disease 2019 (Covid-19)...

The new Coronavirus (SARS-CoV-2) created a pandemic in the world in late 2019 and early 2020. Unfortunately, despite the increasing...

ABIFINA participa de debate do GT-Farma sobre tecnologia e inovação em Saúde